Mapping the turkey erythrocyte .beta.-receptor: a distance geometry approach

Journal of Medicinal Chemistry
1986.0

Abstract

Extensions and refinements of the receptor mapping method as originally developed by Crippen are presented. In a set of newly developed algorithms measures are taken to reduce the number of required energy parameters to a statistically acceptable degree. The most important measure is the incorporation of lipophilicity as a hydrophobic bonding parameter to describe the binding of parts of the ligands to lipophilic areas on the receptor. In order to test the applicability of our set of programs, we mapped the turkey erythrocyte beta receptor using a data set of Bilezikian. It was found that the experimentally determined free energies of binding can be reasonably described using a nine-point geometrical representation of the receptor site and only six energy parameters. The deduced model predicts that the phenyl rings of phenylethanolamines and phenoxypropanolamines occupy different parts of the receptor site.

Knowledge Graph

Similar Paper

Mapping the turkey erythrocyte .beta.-receptor: a distance geometry approach
Journal of Medicinal Chemistry 1986.0
Computer-aided mapping of the .beta.-adrenoceptor I: Explanation for effect of para substitution on blocking activity at the .beta.-1-adrenoceptor
Journal of Medicinal Chemistry 1992.0
Use of physicochemical parameters in distance geometry and related three-dimensional quantitative structure-activity relationships: A demonstration using Escherichia coli dihydrofolate reductase inhibitors
Journal of Medicinal Chemistry 1985.0
Quantitative evaluation of the .beta.2-adrenoceptor affinity of phenoxypropanolamines and phenylethanolamines
Journal of Medicinal Chemistry 1985.0
A general distance-geometry three-dimensional receptor model for diverse dihydrofolate reductase inhibitors
Journal of Medicinal Chemistry 1984.0
Genetically Evolved Receptor Models: A Computational Approach to Construction of Receptor Models
Journal of Medicinal Chemistry 1994.0
Biophysical Mapping of the Adenosine A<sub>2A</sub> Receptor
Journal of Medicinal Chemistry 2011.0
Mapping of the .beta.2-adrenoceptor on Chang liver cells. Differences between high- and low-affinity receptor states
Journal of Medicinal Chemistry 1988.0
Validation of EGSITE2, a Mixed Integer Program for Deducing Objective Site Models from Experimental Binding Data
Journal of Medicinal Chemistry 1997.0
Analysis of cocaine receptor site ligand binding by three-dimensional Voronoi site modeling approach
Journal of Medicinal Chemistry 1993.0